{"filing":{"accession":"0001106578-26-000123","url":"/filing/0001106578-26-000123","form_type":"4","issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_name_source":null,"issuer_ticker":"UTHR","issuer_url":"/issuer/0001082554","period_of_report":"2026-08-18","filed_date":"2026-08-19","acceptance_dt":"2026-08-19T16:33:51+00:00","acceptance_label":"2026-08-19 16:33 UTC","ingested_at":"2026-08-20T05:22:56.381658+00:00","ingested_label":"2026-08-20 05:22 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000123-index.htm","day_url":"/filings/2026-08-19"},"owners":[{"owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","url":"/insider/0001106578","anchor":"owner-0001106578","role":"Director, Officer (Chairperson & CEO)","officer_title":"Chairperson & CEO","is_director":true,"is_officer":true,"is_ten_percent":false,"is_other":false,"filing_anchor":"/filing/0001106578-26-000123#owner-0001106578"}],"line_owners":[{"owner_name":"ROTHBLATT MARTINE A","role":"Director, Officer (Chairperson & CEO)"}],"transactions":[{"id":9298794,"accession":"0001106578-26-000123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001106578-26-000123","line_url":"/filing/0001106578-26-000123#line-1","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239.0,"shares_display":"239","price_per_share":509.4837,"price_display":"509.48","price_state":"stated","total_value":121766.6043,"total_display":"121,766.60","total_whole":"121,767","shares_owned_after":333704.0,"shares_owned_after_display":"333,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298795,"accession":"0001106578-26-000123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001106578-26-000123","line_url":"/filing/0001106578-26-000123#line-2","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":231.0,"shares_display":"231","price_per_share":510.4728,"price_display":"510.47","price_state":"stated","total_value":117919.2168,"total_display":"117,919.22","total_whole":"117,919","shares_owned_after":333473.0,"shares_owned_after_display":"333,473","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298796,"accession":"0001106578-26-000123","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001106578-26-000123","line_url":"/filing/0001106578-26-000123#line-3","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":170.0,"shares_display":"170","price_per_share":511.5941,"price_display":"511.59","price_state":"stated","total_value":86970.997,"total_display":"86,971.00","total_whole":"86,971","shares_owned_after":333303.0,"shares_owned_after_display":"333,303","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298797,"accession":"0001106578-26-000123","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001106578-26-000123","line_url":"/filing/0001106578-26-000123#line-4","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":439.0,"shares_display":"439","price_per_share":513.0605,"price_display":"513.06","price_state":"stated","total_value":225233.5595,"total_display":"225,233.56","total_whole":"225,234","shares_owned_after":332864.0,"shares_owned_after_display":"332,864","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298798,"accession":"0001106578-26-000123","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001106578-26-000123","line_url":"/filing/0001106578-26-000123#line-5","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1264.0,"shares_display":"1,264","price_per_share":514.1759,"price_display":"514.18","price_state":"stated","total_value":649918.3376,"total_display":"649,918.34","total_whole":"649,918","shares_owned_after":331600.0,"shares_owned_after_display":"331,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298799,"accession":"0001106578-26-000123","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001106578-26-000123","line_url":"/filing/0001106578-26-000123#line-6","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2333.0,"shares_display":"2,333","price_per_share":514.9866,"price_display":"514.99","price_state":"stated","total_value":1201463.7378,"total_display":"1,201,463.74","total_whole":"1,201,464","shares_owned_after":329267.0,"shares_owned_after_display":"329,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298800,"accession":"0001106578-26-000123","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001106578-26-000123","line_url":"/filing/0001106578-26-000123#line-7","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1880.0,"shares_display":"1,880","price_per_share":516.0448,"price_display":"516.04","price_state":"stated","total_value":970164.224,"total_display":"970,164.22","total_whole":"970,164","shares_owned_after":327387.0,"shares_owned_after_display":"327,387","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298801,"accession":"0001106578-26-000123","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001106578-26-000123","line_url":"/filing/0001106578-26-000123#line-8","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":873.0,"shares_display":"873","price_per_share":517.089,"price_display":"517.09","price_state":"stated","total_value":451418.697,"total_display":"451,418.70","total_whole":"451,419","shares_owned_after":326514.0,"shares_owned_after_display":"326,514","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298802,"accession":"0001106578-26-000123","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001106578-26-000123","line_url":"/filing/0001106578-26-000123#line-9","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1630.0,"shares_display":"1,630","price_per_share":518.1853,"price_display":"518.19","price_state":"stated","total_value":844642.039,"total_display":"844,642.04","total_whole":"844,642","shares_owned_after":324884.0,"shares_owned_after_display":"324,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9298803,"accession":"0001106578-26-000123","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001106578-26-000123","line_url":"/filing/0001106578-26-000123#line-10","is_derivative":false,"issuer_cik":"0001082554","issuer_name":"UNITED THERAPEUTICS Corp","issuer_ticker":"UTHR","issuer_name_source":null,"issuer_url":"/issuer/0001082554","owner_cik":"0001106578","owner_name":"ROTHBLATT MARTINE A","owner_display_name":"ROTHBLATT MARTINE A","owner_url":"/insider/0001106578","role":"Director, Officer (Chairperson & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairperson & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":441.0,"shares_display":"441","price_per_share":518.6476,"price_display":"518.65","price_state":"stated","total_value":228723.5916,"total_display":"228,723.59","total_whole":"228,724","shares_owned_after":324443.0,"shares_owned_after_display":"324,443","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-19","scope":"global","indirect_nature":"by Trust","deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":10,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-20T05:22:56.381658+00:00","retrieved_label":"2026-08-20 05:22 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000123-index.htm","accepted_at":"2026-08-19T16:33:51+00:00","accepted_label":"2026-08-19 16:33 UTC"},"related":[],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001106578-26-000123","retrieved_at":"2026-08-27T08:59:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}